I am not thinking that - but you asked for an explanation of riskyrider’s post and as I understand where s/he‘s coming from I just answered your question.
It’s the nature of innovation that something better than paxalisib will come along at some point. I can only hope that for patients with GBM because the paxalisib Phase II interim data, as good as it is vs. SOC, is far from a cure for them.
How does GBM AGILE work?, page-34
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)